Event Details
2024 National Lipid Association (NLA) Scientific Sessions
May 30 - Jun 2, 2024
Title: ENCORE - PLOZASIRAN (ARO-APOC3), DECREASES APOC3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH MIXED DYSLIPIDEMIA: MUIR FINAL RESULTS
Date/Time: May 31, 2024, 2:30 p.m. PST
Presenter: Christie M Ballantyne, M.D.
Session: Poster
Title: ENCORE - PLOZASIRAN (ARO-APOC3), AN INVESTIGATIONAL RNAI THERAPEUTIC, DEMONSTRATES PROFOUND AND DURABLE REDUCTIONS IN APOC-3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG), SHASTA-2 FINAL RESULTS
Date/Time: June 1, 2024, 12:20 p.m. PST
Presenter: Christie M Ballantyne, M.D.
Session: Late Breaker